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Congenital heart diseases (CHD) requiring intervention in the 1st month of life to ensure survival is considered as critical CHD (CCHD). CCHD has an incidence of about 
170 in 100,000 live births. Early diagnosis and timely therapy are 
crucial to prevent acute deterioration of the affected children [1]. 
CHD with right-sided obstruction or well-mixing lesion present 
predominately with cyanosis. These cyanotic CHD initially 
present with faint cyanosis which may be indistinguishable 
clinically. Thus, the clinical examination (CE) fails to identify 
about 50% of CHD in the neonatal period [2]. However, these 
babies can be identified with low oxygen saturation (SpO2) in the 
pulse oximeter. Hence, American Academy of Pediatrics (AAP) 
has recommended SpO2 measurement by pulse oximeter as a 
screening strategy to identify cyanotic CHD [3].
However, left-sided obstructive lesions such as hypoplastic 
left heart syndrome, interrupted aortic arch, and coarctation of 
aorta present initially with poor peripheral perfusion. SpO2 may 
remain within normal limits at an early stage of the disease and can 
be missed by pulse oximeter screening [1]. Studies have shown 
that more than 3% difference in saturation (DSpO2) between pre-
ductal and post-ductal regions may give a clue to these left-sided 
obstructive heart diseases [4]. Granelli and Ostman-Smith have 
found that peripheral perfusion index (PI) measured with new 
generation pulse oximeter can help in screening for left-sided 
obstructive lesions [5]. PI is a measure of the pulsatile blood flow 
in the underlying tissues and is decreased in babies with reduced 
peripheral tissue perfusion [6]. PI below 0.7 was suggested as 
a screening tool for identifying left-sided obstructive heart 
diseases [5].
This study was planned with a hypothesis that combining PI 
with SpO2 may improve CCHD detection. The primary objective 
was to compare the diagnostic accuracy of SpO2 alone, with SpO2 
and PI in screening for CCHD among asymptomatic newborn 
babies at 24–72 h of life. The secondary objective was to find out 
the diagnostic accuracy of CE in screening for CCHD either alone 
or in combination with SpO2 and PI.
METHODOLOGY
This prospective study was done in a tertiary care hospital in the 
Tamil Nadu state of India. The study was carried out over a period 
of 4 months from October 2011 to January 2012. The Institutional 
Ethics Committee approved the study. All babies born during the 
study period and asymptomatic at 24–72 h of life were included in 
the study. Asymptomatic babies under evaluation for sepsis due to 
various perinatal risk factors were excluded from the study.
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Parents of all babies who satisfied the inclusion criteria were 
approached for the study. Written informed consent was obtained 
from the parents and basic demographic details were collected. 
Babies were then clinically examined for any dysmorphic 
features, central cyanosis, respiratory distress, apical impulse 
location, femoral pulses, and grade ≥3/6 precordial murmur.
The new generation pulse oximeter with signal extraction 
technology (Masimo, RADICAL-7, Signal extraction pulse 
Co-Oximeter with rainbow technology) was used for recording 
functional hemoglobin SpO2 percentage and PI. The instrument 
displays the pulse waveform, heart rate, SpO2, and PI. The reusable 
neonatal probe was applied in the right hand (Pre-ductal area) and 
the left foot (Post-ductal area) serially when the baby was calm 
and quiet. The SpO2 and PI were recorded, once the monitor’s 
display panel showed regular pulse waves. The probe was cleaned 
with a compatible disinfectant solution between babies.
If PI was ≥0.7 with SpO2 ≥95% in the both tested limbs 
and DSpO2 between the two limbs was ≤3%, the screening was 
considered negative. If anyone of these readings was abnormal, 
the test was repeated after 1 h. If the second recording result 
remained abnormal, it was reconfirmed by repeating the test 
3rd time after another hour. Babies who consistently had SpO2 
<95% or PI <0.7 or DSpO2 >3% in all three recordings were 
declared screen positive. SpO2 <90% in either limb at any time 
either in the initial recording or in the repeat recordings was 
immediately declared as screen positive without further testing. 
All babies with positive screening and those babies with abnormal 
clinical findings underwent echocardiography (Philips ER 
VISION-HD-7 with pediatric probe) by a pediatric cardiologist 
with 5-year experience in the field. Confirmed CCHD cases were 
referred to cardiothoracic surgeons for further management.
The screen negative cases were followed up clinically at 
6 weeks of age when they attended the well-baby clinic for 
review and vaccination. Any suspicion of CHD was confirmed 
by echocardiography. The parents of babies who did not come for 
follow-up were tracked through phone about the health status of 
the baby. For those parents who could not be contacted by phone, 
a letter enquiring the health status of their baby was posted to 
their mailing address. The babies who could not be contacted by 
phone or post were considered as dropouts.
Sensitivity, specificity, positive predictive value (PPV), and 
negative predictive value (NPV) for SpO2, PI, and CE were 
calculated individually and in combination using OpenEpi, 
Version 2, open source calculator for diagnostic tests. Categorical 
data were analyzed with two-tailed Fisher’s exact test for small 
groups and Chi-square test for the large population using SPSS 
Version 16. p<0.05 was considered as significant.
RESULTS
A total of 1011 babies out of 1059 eligible babies were screened. 
48 babies were discharged before 24 h of life due to various 
reasons and were not included in the study (Fig. 1).
Male to female ratio in the study population was 1.03:1. The 
babies were screened at a mean age of 34 h (±10.5), and their 
mean birth weight was 2850 g (±440) (Table 1).
Mean SpO2 in the right hand and left foot was 97.42% (±1.35) 
and 97.58% (±1.44), respectively, with a mean DSpO2 of 1.07% 
(±0.86). Mean PI in the right hand and left foot was 2.43 (±1.48) 
and 2.43 (±1.32), respectively (Table 2).
We had four screen positive cases: One at first recording and 
other three at the end of three recordings. The baby who was 
screen positive at first recording had SpO2 <90% and PI< 0.7 
in the right hand. This baby was antenatally diagnosed to have 
single ventricle. Postnatal echocardiogram of this baby showed 
transposition of great vessels (TGV), interrupted aortic arch, 
single ventricle, hypoplastic left atrioventricular valve, and patent 
ductus arteriosus. Three babies persistently had SpO2 90–94% 
Figure 1: Flow of cases through the study
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at all three recordings. Echocardiogram in these babies showed 
tetralogy of fallot (TOF) with severe right ventricular outlet 
obstruction in one baby, right ventricular dysplasia with severe 
right ventricular outlet obstruction in the second baby and 
structurally normal heart in another baby. The baby with TOF 
was antenatally diagnosed to have CHD and postnatally had 
systolic murmur by CE. The other two cases had normal antenatal 
scans and normal CE. The screen positive baby with normal echo 
subsequently had normal SpO2 before discharge.
Thus, two babies antenatally detected to have CCHD had 
positive screen by pulse oximeter. Four babies had systolic murmur 
in CE, and this includes one screen positive baby with TOF. The 
other three babies with systolic murmur and negative pulse oximeter 
screening were found to have ventricular septal defect (VSD) by 
echocardiogram. In addition, four babies with dysmorphic features 
underwent echocardiography as a part of dysmorphology work up, 
and all were found to have a structurally normal heart (Table 2).
Other cases were followed up at 6 weeks of age. A total of 856 
babies came for follow-up, and none had clinical features of CHD. 
144 babies who did not turn for follow-up were contacted by phone 
and were reported to be healthy without any symptoms suggestive 
of CCHD. Thus, the incidence of CCHD in our population was 
2.97/1000 babies, and the incidence of CHD was 5.93/1000 babies.
The diagnostic accuracy of SpO2, PI, and CE was calculated 
individually and in combination. The sensitivity, specificity, PPV, 
and NPV of SpO2 alone and SpO2 with PI were similar. PI alone 
has low sensitivity but better PPV compared to SpO2. If the role of 
PI alone in identifying left-sided obstructive lesions is considered 
then the sensitivity is 100% and specificity is 100%. CE has low 
sensitivity and PPV compared to SpO2. When all three methods 
of screening are combined, i.e., SpO2, PI, and CE the sensitivity is 
100%, specificity is 99.7%, and PPV is 50% with a false positivity 
rate of 50% in identifying CCHD (Table 3).
DISCUSSION
In this study, an attempt was made to study the role of combined 
SpO2 and PI screening in identifying the CCHD. The results are 
encouraging since PI has rightly identified one baby with the 
interrupted aortic arch. Interestingly, this baby also had SpO2 <90% 
due to TGV and single ventricle. It can be assumed that even if it 
had been an isolated interrupted aortic arch, this case would have 
been picked up by pulse oximeter when both SpO2 and PI were 
recorded in all babies. Thus, PI and SpO2, each have a unique 
role as a screening tool for identifying left-sided obstructive heart 
diseases and cyanotic heart diseases, respectively.
de-Wahl Granelli et al. have suggested that incorporating 
cutoff values for PI into routine pulse oximetry screening would 
probably increase sensitivity for detection of the left heart 
obstructive disease [4]. In our study, the PI <0.7 has a sensitivity 
of 33.33%, specificity of 100%, and PPV of 100% in identifying 
all CCHD. However, it has a sensitivity of 100% and specificity 
of 100% in identifying CCHD with the left-sided obstructive 
lesion since there was only one case with the interrupted aortic 
arch in the study population which was identified by low PI.
de-Wahl Granelli et al. stated that in a complex heart disease 
with a combination of TGV, arch obstruction and duct dependent 
circulation, the post-ductal saturation may well be >95%, and 
hence, >3% DSpO2 between pre-ductal and post-ductal regions 
was included as a screening tool in their study [4]. Although we 
had one baby with TGV and aortic arch obstruction, the DSpO2 
was not significant. Probably this was due to the complex nature 
of the defect with single ventricle physiology which resulted in 
SpO2 <90% in both pre-ductal and post-ductal areas.
There were two babies in this study with antenatally detected 
CHD whose SpO2 screening was positive and echo later 
confirmed the critical cardiac lesions. This supports Richmond 
et al.’s comment that even if the antenatal diagnosis was not made 
in these babies, the screening saturation measurement would have 
triggered the evaluation for CHD [7]. Riede et al. stated that in 
babies with the prenatal diagnosis of CCHD, if medical treatment 
is initiated soon after birth, SpO2 will be spuriously high because 
of medical therapy [8]. Koppel et al. have noted that in a center 
where fetal echocardiography is readily accessible, many lesions 
will be diagnosed prenatally, and therefore, SpO2 screening may 
be less useful in detecting new CCHD. However, centers, where 
fetal echocardiography is performed less frequently, are likely to 
demonstrate higher yields from pulse oximetry screening [9].
Although CE is said to miss about 50% of CHD in infants, 
many studies on CHD screening have included the CE in their 
Table 1: Baseline characteristics of the study population
Characteristics Observation
Male: female ratio 1.03:1 (p=0.687)
Mean birth weight 2850 (±440) g
Mean age at screening 34.03 (±10.5) h
Mode of delivery Labor naturale-453;
Cesarean section-532;
Assisted breech-3;
Outlet forceps-17;
Vacuum-6
Table 2: Study results
Characteristics Observation
Mean SpO2 in right hand 97.42% (±1.35)
Mean SpO2 in left foot 97.58% (±1.44)
Mean DSpO2 1.07% (±0.86)
Mean PI in right hand 2.43 (±1.48)
Mean PI in left foot 2.43 (±1.32)
Number of babies with 
dysmorphism
4 (down syndrome-1,
Preauricular skin tag-3)
Number of babies with 
cardiac murmur
4 (CCHD-1,
VSD-3)
Number of screen positive 
cases
4 (Low SpO2 and low PI-1,
low SpO2-3)
Number of confirmed CCHD 3 (Antenatally detected-2,
detected by screening-1)
SpO2: Pulse oximeter saturation, DSpO2: Difference in pulse oximeter saturation 
between right upper limb and left lower limb, PI: Perfusion index, CCHD: Critical 
congenital heart disease, VSD: Ventricular septal defect
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protocol [7-10]. In this study, though CE failed to pick up two 
CCHD, it has identified three screen negative babies with VSD. 
This stresses the importance of clinical evaluation for CHD in 
all babies, including the screen negative babies, at least once 
before discharge. In developing countries, where delay in 
seeking medical care for sick babies is a common occurrence, 
early recognition of this non CCHD may also play a key role in 
influencing CHD related mortality.
Thangaratinam et al. on the basis of eight studies have found 
that in pulse oximeter screening, the summary estimates of 
sensitivity and specificity were 63% and 99.8%, respectively, 
yielding a false positive rate of 0.2% [2]. Valmari based on 10 
studies found a high specificity (99.9–99.99%), and the overall 
rate of detection of 15 specified defects with pulse oximetry was 
72%, which exceeds that of the CE (58%) [11]. In this study, the 
diagnostic value of SpO2 in diagnosing CCHD has a sensitivity 
of 100%, specificity of 99.9%, and PPV of 75% with the false 
positivity rate of 25%.
Liske et al. have defined CCHD as heart diseases that require 
intervention or cause death within 1 month of age in contrast to 
AAP definition of up to 1 year of age [1,3]. The follow-up in this 
study was limited to 6 weeks of age, as patient compliance with 
long-term follow-up is poor in this study scenario. Ideally, pulse 
oximetry and echo have to be done for all babies [12]. However, 
this is not practically feasible in large community studies. Hence, 
in most of the studies, authors have done echo only for screen 
positive cases and have clinically followed the screen negative 
cases for manifestations of CCHD [4,8].
The study has following limitations: It is a hospital-based 
study done with small sample size, and clinical follow-up was 
not available for 15% of babies at 6 weeks of age. Hence, this 
may not reflect the true screening scenario at the community 
level. However, this study has tried to address the challenge in 
identifying left side obstructive heart diseases with pulse oximetry 
by including PI measurement in the screening protocol.
CONCLUSION
In our study, PI was low in one baby with left-sided obstructive 
lesion, but due to coexisting single ventricle physiology, SpO2 
was also low. Hence, in this study, there was no difference in the 
diagnostic accuracy between SpO2 alone and SpO2 with PI in 
screening for CCHD. However, the study was limited by small 
sample size. Thus, combining PI with SpO2 may improve CCHD 
screening using pulse oximeter but large-scale study is needed.
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SpO2 and CE 100 (43.85, 100) 99.7 (99.13, 99.9) 50 (18.76, 81.24) 100 (99.62,100)
SpO2, PI and 
CE
100 (43.85, 100) 99.7 (99.13, 99.9) 50 (18.76, 81.24) 100 (99.62, 100)
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